GE HealthCare Technologies Inc.
For the period ended Jun 30, 2025. Filed Jul 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Jul 30, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Results of Operations – Segments
We exclude from Segment EBIT certain corporate-related expenses and certain transactions or adjustments that our Chief Operating Decision Maker (which is our Chief Executive Officer) considers to be non-operational, such as Interest and other financial charges – net, Benefit (provision) for income taxes, restructuring costs, acquisition and disposition-related benefits (charges), Spin-Off and separation costs, Non-operating benefit (income) costs, gain (loss) on business and asset dispositions, amortization of acquisition-related intangible assets, Net (income) loss attributable to noncontrolling interests, Income (loss) from discontinued operations, net of taxes, and investment revaluation gain (loss). See Note 3, “Segment Information” for additional information on our reportable segments, and “Results of Operations” above for discussion on segment revenue performance.
| Segment EBIT | For the three months ended June 30 | For the six months ended June 30 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | % of segment revenues | 2024 | % of segment revenues | % change | 2025 | % of segment revenues | 2024 | % of segment revenues | % change | |
| Imaging | $188 | 8.5% | $208 | 9.6% | (10)% | $387 | 8.9% | $373 | 8.8% | 3% |
| AVS | 267 | 20.7% | 255 | 20.5% | 4% | 528 | 20.9% | 512 | 20.7% | 3% |
| PCS | 60 | 7.7% | 78 | 10.1% | (23)% | 108 | 7.0% | 159 | 10.5% | (32)% |
| PDx | 213 | 29.3% | 200 | 31.2% | 7% | 418 | 30.7% | 378 | 30.5% | 11% |
Imaging Segment EBIT was $188 million, a decrease of $20 million primarily due to cost inflation, including the impacts of incremental tariffs, partially offset by cost productivity;
AVS Segment EBIT was $267 million, an increase of $11 million due to growth in sales volume and cost productivity, largely offset by cost inflation, including the impacts of incremental tariffs;
PCS Segment EBIT was $60 million, a decrease of $18 million primarily due to cost inflation and unfavorable mix, partially offset by cost productivity; and
PDx Segment EBIT was $213 million, an increase of $14 million due to an increase in price and growth in sales volume, partially offset by increased investment.
Imaging Segment EBIT was $387 million, an increase of $13 million due to cost productivity, growth in sales volume, and an increase in price, partially offset by cost inflation, including the impacts of incremental tariffs;
AVS Segment EBIT was $528 million, an increase of $15 million due to growth in sales volume and cost productivity, largely offset by cost inflation, including the impacts of incremental tariffs;
PCS Segment EBIT was $108 million, a decrease of $51 million due to cost inflation and unfavorable mix; and
PDx Segment EBIT was $418 million, an increase of $41 million due to an increase in price and growth in sales volume, partially offset by increased investment.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.